Xiaoyuan Zi

2.6k total citations
20 papers, 909 citations indexed

About

Xiaoyuan Zi is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xiaoyuan Zi has authored 20 papers receiving a total of 909 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Xiaoyuan Zi's work include Liver physiology and pathology (5 papers), MicroRNA in disease regulation (5 papers) and Pluripotent Stem Cells Research (3 papers). Xiaoyuan Zi is often cited by papers focused on Liver physiology and pathology (5 papers), MicroRNA in disease regulation (5 papers) and Pluripotent Stem Cells Research (3 papers). Xiaoyuan Zi collaborates with scholars based in China, United States and Panama. Xiaoyuan Zi's co-authors include Xinghua Pan, Sherman M. Weissman, Rong Fan, Yiping Hu, Haiying Zhu, Ye Wang, Wei Luo, H.-Y. Zhu, Fu Yang and Yinghao Sun and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Xiaoyuan Zi

19 papers receiving 897 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaoyuan Zi China 14 614 163 125 117 98 20 909
Chaoqun Wang China 18 468 0.8× 163 1.0× 118 0.9× 69 0.6× 75 0.8× 47 731
Qian Guo China 14 710 1.2× 140 0.9× 109 0.9× 37 0.3× 122 1.2× 43 994
Leiming Xu China 17 362 0.6× 196 1.2× 258 2.1× 77 0.7× 193 2.0× 43 1.0k
Chi‐Hung Tzang Hong Kong 11 359 0.6× 131 0.8× 51 0.4× 44 0.4× 129 1.3× 13 718
Xuefeng Xia China 14 363 0.6× 257 1.6× 109 0.9× 57 0.5× 192 2.0× 33 777
Cheolhee Won South Korea 19 577 0.9× 144 0.9× 132 1.1× 37 0.3× 238 2.4× 33 1.0k
Xiangyu Wang China 16 640 1.0× 231 1.4× 90 0.7× 37 0.3× 82 0.8× 42 877
Zixi Wang China 14 328 0.5× 85 0.5× 36 0.3× 98 0.8× 89 0.9× 31 656
Heng Sun China 14 331 0.5× 196 1.2× 159 1.3× 33 0.3× 228 2.3× 25 740
Xinyuan Zhao China 17 666 1.1× 54 0.3× 65 0.5× 47 0.4× 85 0.9× 28 1.0k

Countries citing papers authored by Xiaoyuan Zi

Since Specialization
Citations

This map shows the geographic impact of Xiaoyuan Zi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Zi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Zi more than expected).

Fields of papers citing papers by Xiaoyuan Zi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyuan Zi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Zi. The network helps show where Xiaoyuan Zi may publish in the future.

Co-authorship network of co-authors of Xiaoyuan Zi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Zi. A scholar is included among the top collaborators of Xiaoyuan Zi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Zi. Xiaoyuan Zi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Minli, Hongde Liu, Yunxia Guo, et al.. (2020). Single symbiotic cell transcriptome sequencing of coral. Genomics. 112(6). 5305–5312. 4 indexed citations
3.
Wang, Mengchao, Zhiheng Wang, Xiaosong Zhi, et al.. (2020). SOX9 enhances sorafenib resistance through upregulating ABCG2 expression in hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 129. 110315–110315. 26 indexed citations
4.
Wang, Mengchao, Zhiheng Wang, Xiaosong Zhi, et al.. (2019). Sox9 Enhances Sorafenib Resistance Through Upregulating ABCG2 Expression in Hepatocellular Carcinoma. SSRN Electronic Journal. 1 indexed citations
5.
Zhi, Xiaosong, Jun Xiong, Mengchao Wang, et al.. (2018). Physiological Hypoxia Enhances Stemness Preservation, Proliferation, and Bidifferentiation of Induced Hepatic Stem Cells. Oxidative Medicine and Cellular Longevity. 2018(1). 7618704–7618704. 13 indexed citations
6.
Yang, Lihua, Ye Wang, Qiao Shi, et al.. (2018). Liver-enriched activator protein 1 as an isoform of CCAAT/enhancer-binding protein beta suppresses stem cell features of hepatocellular carcinoma. Cancer Management and Research. Volume 10. 873–885. 11 indexed citations
7.
Ye, Chen, Chao Zhang, Hai Huang, et al.. (2018). The Natural Compound Myricetin Effectively Represses the Malignant Progression of Prostate Cancer by Inhibiting PIM1 and Disrupting the PIM1/CXCR4 Interaction. Cellular Physiology and Biochemistry. 48(3). 1230–1244. 76 indexed citations
8.
Zhang, Chunlei, Jun Xiong, Qi Yang, et al.. (2018). Profiling and Bioinformatics Analyses of Differential Circular RNA Expression in Prostate Cancer Cells. Future Science OA. 4(9). FSOA340–FSOA340. 19 indexed citations
9.
Han, Lin, Hua‐Jun Wu, Haiying Zhu, et al.. (2017). Bisulfite-independent analysis of CpG island methylation enables genome-scale stratification of single cells. Nucleic Acids Research. 45(10). gkx026–gkx026. 45 indexed citations
10.
Zeng, Shuxiong, Xiaowen Yu, Chong Ma, et al.. (2017). Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma. Scientific Reports. 7(1). 3151–3151. 61 indexed citations
11.
Zhi, Xiaosong, Jun Xiong, Xiaoyuan Zi, & Yiping Hu. (2016). The potential role of liver stem cells in initiation of primary liver cancer. Hepatology International. 10(6). 893–901. 8 indexed citations
12.
Guo, Shangqin, Xiaoyuan Zi, Vincent Schulz, et al.. (2014). Nonstochastic Reprogramming from a Privileged Somatic Cell State. Cell. 156(4). 649–662. 137 indexed citations
13.
Han, Lin, Xiaoyuan Zi, Lana X. Garmire, et al.. (2014). Co-detection and sequencing of genes and transcripts from the same single cells facilitated by a microfluidics platform. Scientific Reports. 4(1). 6485–6485. 62 indexed citations
14.
Yu, Bing, Zhiying He, Pu You, et al.. (2013). Reprogramming Fibroblasts into Bipotential Hepatic Stem Cells by Defined Factors. Cell stem cell. 13(3). 328–340. 128 indexed citations
15.
Wang, Ye, Fu Yang, Xiaoyuan Zi, et al.. (2013). Cuprous oxide nanoparticles inhibit the growth and metastasis of melanoma by targeting mitochondria. Cell Death and Disease. 4(8). e783–e783. 138 indexed citations
16.
He, Zhiying, Li Deng, Yangfang Li, et al.. (2012). Murine embryonic stem cell-derived hepatocytes correct metabolic liver disease after serial liver repopulation. The International Journal of Biochemistry & Cell Biology. 44(4). 648–658. 13 indexed citations
17.
Pan, Xinghua, R. Durrett, Haiying Zhu, et al.. (2012). Two methods for full-length RNA sequencing for low quantities of cells and single cells. Proceedings of the National Academy of Sciences. 110(2). 594–599. 90 indexed citations
18.
Su, Juan, Pu You, Shaohua Song, et al.. (2011). A potential role for the homeoprotein Hhex in hepatocellular carcinoma progression. Medical Oncology. 29(2). 1059–1067. 20 indexed citations
19.
He, Zhiying, Haibin Zhang, Xin Zhang, et al.. (2010). Liver Xeno-Repopulation with Human Hepatocytes in Fah−/−Rag2−/− Mice after Pharmacological Immunosuppression. American Journal Of Pathology. 177(3). 1311–1319. 39 indexed citations
20.
Zi, Xiaoyuan, Yucheng Yao, Haiying Zhu, et al.. (2006). Long‐term persistence of hepatitis B surface antigenand antibody induced by DNA‐mediated immunization results in liver and kidney lesions in mice. European Journal of Immunology. 36(4). 875–886. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026